Mundipharma A/S: Financial statements 2018
CVR: 17981994
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Mundipharma A/S (CVR 17981994) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 55,436,000 and a net result of DKK -152,000 compared with DKK -8,267,000 the year before. That is a decrease of 12.4% compared with the year before. The profit margin was -0.3%. Equity in the 2018 report amounted to DKK 47,287,000. The solvency ratio was 34.6%. The company had 26 employees in the financial year.
- Revenue
- DKK 55,436,000
- Gross Profit
- DKK 24,872,000
- Profit/Loss
- DKK -152,000
- Equity
- DKK 47,287,000
- Total Assets
- DKK 136,685,000
- Employees
- 26
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 55.4M | 24.9M | -152K | 47.3M | 26 |
| 2017 | 63.3M | 25.4M | -8.3M | 47.4M | 23 |
| 2016 | 73M | 24.2M | 2.4M | 55.7M | 41 |
| 2015 | 2.8B | - | 51.5M | 128.3M | 39 |
| 2014 | 2.4B | 77.5M | 33.8M | 76.8M | 44 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Mundipharma A/S has published its annual report for 2017. Revenue came to DKK 63,266,000, and the net result was DKK -8,267,000.
As of April 1, 2018, Stuart David Baker has joined the board of directors of Mundipharma A/S.
As of April 1, 2018, Åke Gunnar Wikström has joined the board of directors of Mundipharma A/S.
As of April 1, 2018, Christopher Benbow Mitchell has left the board of directors of Mundipharma A/S.
As of March 31, 2018, Stuart David Baker has left the board of directors of Mundipharma A/S.
As of February 1, 2018, Kjetil Kollstad is registered as adm. dir. of Mundipharma A/S.
As of February 1, 2018, Anders With Fogstrup has stepped down as director of Mundipharma A/S.
About Mundipharma A/S
Mundipharma A/S is a Danish company of the type Aktieselskab based in Vedbæk, founded in 1994. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Norpharma A/S and NORPHARMA A/S. The management consists of Lisbeth Kattenhøj. The board consists of Stephen Johan Jamieson (chair), Bryan George Lea and Lisbeth Kattenhøj. The company is owned by Halm S.à.r.l., RSS Captain Trust Holdings LLC and JDS Captain Trust Holdings LLC. The company has 3 employees (2026). In 2025, the company reported revenue of DKK 25,912,000 and a net result of DKK 672,000 compared with DKK 514,000 the year before. Equity in the 2025 report amounted to DKK 38,165,000.
